Biosynex SARL acquired Sensogen Deutschland GmbH.
Biosynex SARL (ENXTPA:ALBIO) completed the acquisition of Sensogen Deutschland GmbH on October 29, 2012.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 EUR | +0.48% | -20.38% | -49.46% |
04-30 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-29 | Biosynex: agreement for ProciseDx in North America | CF |
1st Jan change | Capi. | |
---|---|---|
-49.46% | 48.27M | |
-9.59% | 7.67B | |
-1.20% | 5.41B | |
+21.55% | 4.62B | |
+0.02% | 4.57B | |
-54.22% | 3.22B | |
+6.42% | 2.59B | |
-14.95% | 2.05B | |
-8.29% | 1.79B | |
+1.18% | 1.76B |